Last update 04 Nov 2024

Friluglanstat

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NS 580, NS-580, NS580
Target
PGES
Mechanism
PGES inhibitors(Prostaglandin E synthase inhibitors)
Therapeutic Areas
Nervous System DiseasesUrogenital Diseases
Active Indication
Chronic pelvic pain syndromeChronic prostatitisEndometriosis
Inactive Indication-
Originator Organization
Nippon Shinyaku Co., Ltd.Nippon Shinyaku Co., Ltd.
Active Organization
Nippon Shinyaku Co., Ltd.Nippon Shinyaku Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC25H20ClF3N4O3
InChIKeyZPONWJXTHMDOSV-UHFFFAOYSA-N
CAS Registry1422203-86-8

Related

6
Clinical Trials associated with Friluglanstat
JPRN-jRCT2031230134 / RecruitingPhase 2IIT
Exploratory placebo-controlled double-blind study of NS-580 in patients with chronic prostatitis/chronic pelvic pain syndrome (early phase II)
JPRN-jRCT2071220031 / CompletedPhase 1IIT
Drug-drug interaction study of NS-580 in Healthy male subjects (Phase I Study)
JPRN-jRCT2071220011 / CompletedPhase 1IIT
Clinical Pharmacology Study of NS-580 in Healthy female subjects (Phase I Study)
100 Clinical Results associated with Friluglanstat
Login to view more data
100 Translational Medicine associated with Friluglanstat
Login to view more data
100 Patents (Medical) associated with Friluglanstat
Login to view more data
100 Deals associated with Friluglanstat
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic pelvic pain syndromePhase 2
JP
Nippon Shinyaku Co., Ltd.Nippon Shinyaku Co., Ltd.
01 Jun 2023
Chronic prostatitisPhase 2
JP
Nippon Shinyaku Co., Ltd.Nippon Shinyaku Co., Ltd.
01 Jun 2023
EndometriosisPhase 2
JP
Nippon Shinyaku Co., Ltd.Nippon Shinyaku Co., Ltd.
22 Apr 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free